ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AIMDW Ainos Inc

0.07
0.00 (0.00%)
After Hours
Last Updated: 16:00:03
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 0.0429
Ask Price 0.077
News -
Company Name Stock Ticker Symbol Market Type
Ainos Inc AIMDW NASDAQ Equity Warrant
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.07 16:00:03
Open Price Low Price High Price Close Price Prev Close
0.07 0.07
Trades Volume Avg Volume
0 0 -
Last Trade Time Type Quantity Stock Price Currency
- 0  0.07 USD

Ainos Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 439.90k - - - -0.01
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Ainos

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No AIMDW Message Board. Create One! See More Posts on AIMDW Message Board See More Message Board Posts

AIMDW Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

Ainos is a diversified healthcare company focused on the development of novel point-of-care testing (POCT), low-dose VELDONA interferon therapeutics, and synthetic RNA-driven preventative medicine. The company¿s products include VELDONA clinical-stage human therapeutics, VELDONA Pet cytoprotein health supplements, and telehealth-friendly POCTs powered by its AI Nose technology platform.